167 related articles for article (PubMed ID: 17907374)
21. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?
Kwon YD; Ohe JY; Kim DY; Chung DJ; Park YD
Clin Oral Implants Res; 2011 Jan; 22(1):100-5. PubMed ID: 20946206
[TBL] [Abstract][Full Text] [Related]
22. Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.
Xiong M; Pearson A; Sabino M; Svoboda L; Ehlis E
Northwest Dent; 2010; 89(4):27-33. PubMed ID: 20860270
[No Abstract] [Full Text] [Related]
23. Care required when using bisphosphonates in dental surgical practice.
Goiato MC; dos Santos DM; Rondon BC; Moreno A; Baptista GT; Verri FR; Dekon SF
J Craniofac Surg; 2010 Nov; 21(6):1966-70. PubMed ID: 21119471
[TBL] [Abstract][Full Text] [Related]
24. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
[TBL] [Abstract][Full Text] [Related]
25. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
Kyrgidis A; Koloutsos G; Vahtsevanos K
Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
[No Abstract] [Full Text] [Related]
26. A review of bisphosphonate-associated osteonecrosis of the jaws and its management.
Lam DK; Sándor GK; Holmes HI; Evans AW; Clokie CM
J Can Dent Assoc; 2007 Jun; 73(5):417-22. PubMed ID: 17555652
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
28. Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws.
Kwon YD; Kim DY; Ohe JY; Yoo JY; Walter C
J Oral Maxillofac Surg; 2009 Dec; 67(12):2644-8. PubMed ID: 19925985
[TBL] [Abstract][Full Text] [Related]
29. Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
Bagan JV; Jiménez Y; Gómez D; Sirera R; Poveda R; Scully C
Oral Oncol; 2008 Nov; 44(11):1088-9. PubMed ID: 18396443
[TBL] [Abstract][Full Text] [Related]
30. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
Chu V; ;
Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
[TBL] [Abstract][Full Text] [Related]
31. Bisphosphonate-related osteonecrosis of the jaw.
Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
[TBL] [Abstract][Full Text] [Related]
32. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
Siddiqi A; Payne AG; Zafar S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.
Hewitt C; Farah CS
J Oral Pathol Med; 2007 Jul; 36(6):319-28. PubMed ID: 17559492
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonates and oral health: primer and an update for the practicing surgeon.
Assael LA
Oral Maxillofac Surg Clin North Am; 2011 Aug; 23(3):443-53. PubMed ID: 21798442
[TBL] [Abstract][Full Text] [Related]
36. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
Lee CY; Suzuki JB
Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
[TBL] [Abstract][Full Text] [Related]
37. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
Koka S; Clarke BL; Amin S; Gertz M; Ruggiero SL
Int J Prosthodont; 2007; 20(2):115-22. PubMed ID: 17455429
[TBL] [Abstract][Full Text] [Related]
38. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
Bagan J; Scully C; Sabater V; Jimenez Y
Oral Oncol; 2009 Jul; 45(7):551-4. PubMed ID: 19251474
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonate therapy and dental treatment.
Phillips G
J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
[No Abstract] [Full Text] [Related]
40. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]